Physician profile
Viktor Miro
NPI 1073856019
$367.41
in general payments reported to CMS, 2019-2025
11 companies · $24.69 in 2025
The $24.69 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $67.98 · 2021: $60.37 · 2022: $21.76 · 2023: $60.82 · 2024: $24.92 · 2025: $24.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $110.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $127.42 | 2019-2023 | Xarelto |
| Abbvie INC. | $60.37 | 2021 | |
| Portola Pharmaceuticals, LLC | $33.16 | 2020 | |
| Ironshore Pharmaceuticals INC. | $24.92 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $24.69 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $22.20 | 2020 | |
| Pfizer INC. | $17.00 | 2019 | |
| Merck Sharp & Dohme LLC | $16.00 | 2019 | |
| Allergan, INC. | $15.32 | 2019 | |
| Mallinckrodt Enterprises LLC | $14.50 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Viktor Miro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.